Yi Hsu Huang
Director/Board Member en ADVAGENE BIOPHARMA CO., LTD. .
Perfil
Yi Hsu Huang was the founder of Mycenax Biotech, Inc. founded in 2001, where he held the title of Director from 2013 to 2019.
Currently, he is the Chief Executive Officer-Bioproduction Plant at National Health Research Institutes and a Director at Advagene Biopharma Co., Ltd.
since 2016.
He previously worked as the Chief Technology Officer & Deputy General Manager at Medigen Vaccine Biologics Corp.
Dr. Huang holds a doctorate degree from Auburn University and a graduate degree from Northwestern State University.
Cargos activos de Yi Hsu Huang
| Empresas | Cargo | Inicio |
|---|---|---|
| ADVAGENE BIOPHARMA CO., LTD. | Director/Board Member | 06/04/2016 |
| National Health Research Institutes | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Yi Hsu Huang.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Chief Tech/Sci/R&D Officer | 01/05/2021 |
| MYCENAX BIOTECH INC. | Founder | 15/08/2019 |
Formación de Yi Hsu Huang.
| Auburn University | Doctorate Degree |
| Northwestern State University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| MYCENAX BIOTECH INC. | Health Technology |
| MEDIGEN VACCINE BIOLOGICS CORPORATION | Health Technology |
| ADVAGENE BIOPHARMA CO., LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
| National Health Research Institutes |
- Bolsa de valores
- Insiders
- Yi Hsu Huang
